Transmission Dynamics of SARS-CoV-2(COVID-19) with Vaccine Preventive Measures among Nigerian Populace Using Mathematical Modeling
Oludare Temitope Osuntokun, Adeyemi. O. Binuyo, Muhammad Akram, Gamberini Maria Cristina
International Journal of Pathogen Research · pp. 40–51 · Published 6 Mar 2021
10.9734/ijpr/2021/v6i330164Abstract
SARS-CoV-2(COVID-19) is a very infectious symptomatic and asymptomatic infection caused by Severe Acute Respiratory Syndrome Corona virus 2 (SAR-COV-2). COVID-19 is caused by the SARS-CoV-2 virus, which spreads between people, mainly when an infected person is in close contact with another uninfected person. In this research work, a mathematical model for the novel COVID 19 viral infectious disease which is ravaging the world today including Nigeria was considered.. The mathematical model consists of four different compartments namely, susceptible, infected, vaccine and recovered under convex incident rate. The formulation of the mathematical model and some qualitative aspects for the model including the basic reproductive number of the model, existence of equilibria and its stability results by using various tools of nonlinear analysis were done. On the basis of simulations using Matlab Software package. Dynamical behaviour were observed in the mathematical model due to the vaccine of susceptible and infected individuals or one of those two classes of individuals. The x – rays features of this paper is to formulate and analyse a mathematical model that extends and complements the ones in the literature by incorporating the vaccination class denoted by V(t). Mathematical models are widely used to examine, explain, and state the relevance of the use of vaccines to prevent the spread of the dynamics of infectious diseases (COVID 19) transmission among the Nigerian populace.
References (33)
- 1 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor [DOI]
- 2 A contribution to the mathematical theory of epidemics [DOI]
- 3 The Mathematics of Infectious Diseases [DOI]
- 4 Autoantibodies against type I IFNs in patients with life-threatening COVID-19 [DOI]
- 5 Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts [DOI]
- 6 Prevalence of Asymptomatic SARS-CoV-2 Infection [DOI]
- 7 Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies [DOI]
- 8 Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability [DOI]
- 9 Perspectives on the basic reproductive ratio [DOI]
- 10 TLR3 Deficiency in Patients with Herpes Simplex Encephalitis [DOI]
- 11 Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset [DOI]
- 12 Emerging Pandemic Diseases: How We Got to COVID-19 [DOI]
- 13 Applied Numerical Methods with MATLAB for Engineers and Scientists
- 14 The World Health Organization [DOI]
- 15 Human TRAF3 Adaptor Molecule Deficiency Leads to Impaired Toll-like Receptor 3 Response and Susceptibility to Herpes Simplex Encephalitis [DOI]
- 16 A mathematical model for COVID-19 transmission dynamics with a case study of India [DOI]
- 17 A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection [DOI]
- 18 SARS-CoV-2 Infections and Serologic Responses from a Sample of U.S. Navy Service Members — USS Theodore Roosevelt, April 2020 [DOI]
- 19 Modeling the impact of mass influenza vaccination and public health interventions on COVID-19 epidemics with limited detection capability [DOI]
- 20 Mathematical modeling and the transmission dynamics in predicting the Covid-19 - What next in combating the pandemic [DOI]
- 21 Study of transmission dynamics of novel COVID-19 by using mathematical model [DOI]
- 22 Mathematical Model for the Transmission of Covid-19 with Nonlinear Forces of Infection and the Need for Prevention Measure in Nigeria [DOI]
- 23 Models of CD8+ Responses: 1. What is the Antigen-independent Proliferation Program [DOI]
- 24 MATLAB: An Introduction with Applications
- 25 Human genetics of life-threatening influenza pneumonitis [DOI]
- 26 Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS‐CoV ‐2 drug targets: in vitro validation of furin inhibition [DOI]
- 27 Identification of an IRF3 variant and defective antiviral interferon responses in a patient with severe influenza [DOI]
- 28 Synergistic Efficacy of Aframomum Melegueta [Roscoe] K. Schum and Spondias mombin (Linn), a Predictive Treatment of SARS-CoV-2 (COVID-19) Infection [DOI]
- 29 Yaşlı Kadınlarda Üreme Sağlığı
- 30 Early dynamics of transmission and control of COVID-19: a mathematical modelling study [DOI]
- 31 Will an imperfect vaccine curtail the COVID-19 pandemic in the U.S.? [DOI]
- 32 Journal of Infectious Diseases and Epidemiology [DOI]
- 33 Identification of neutralizing human monoclonal antibodies from Italian Covid-19 convalescent patients [DOI]
Cited by 1
Arindria Sekar Putri Valentinna, Ali Kusnanto, Paian Sianturi · MILANG Journal of Mathematics and Its Applications · 2023
Related research
- Online Information Seeking Behavior among Indonesian during the COVID-19 Pandemic — shares topic coverage
- Determinants of COVID-19 Vaccine Uptake among Health Care Workers: A Case Study of Mogadishu City, Somalia — shares topic coverage
- Assessment of Hepatitis B Vaccine Efficacy, Prevalence of Infection, and Risk Determinants among Expectant Mothers at Antenatal Care in Abyei, South Sudan — shares topic coverage
- Preparation of Fowl Typhoid Vaccine from Field Isolates and Determination of Efficacy — shares topic coverage
- Protection against Helicobacter pylori Infection in BALB/c Mice by Oral or Intramuscular Administration of Multicomponent Vaccine of rCagA +LPS +CpG — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
1
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.